Provectus Biopharmaceuticals, Inc. (PVCT)
$0.06+20.00%Close
SELLRECOVERY · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $25M
- Beta
- 0.90
- P/E (TTM)
- -4.51
- Short % float
- 0.21%
- Days to cover
- 4.8
- SI change
- +0.0%
- 1W
- +20.00%
- 1M
- +0.00%
- vs SPY 1W
- +20.14%
- vs SPY 1M
- -2.51%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on PVCT?
- LOPJLB’s latest quantitative signal on Provectus Biopharmaceuticals, Inc. (PVCT) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is PVCT in?
- Provectus Biopharmaceuticals, Inc. (PVCT) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Provectus Biopharmaceuticals, Inc. (PVCT) do?
- Provectus Biopharmaceuticals, Inc. is a clinical-stage biotechnology firm dedicated to pioneering immunotherapy treatments. These therapies are grounded in its proprietary halogenated xanthene platform. Among its key developments is PV-10, an experimental autolytic cancer immunotherapy. This treatment is being explored for a range of adult solid tumor malignancies, encompassing melanoma and var…